Today: 10 June 2026
XRP price stock: Token slips near $2.12 as Senate pauses crypto bill, Ripple cites Luxembourg nod
15 January 2026
1 min read

XRP price stock: Token slips near $2.12 as Senate pauses crypto bill, Ripple cites Luxembourg nod

New York, Jan 15, 2026, 10:11 ET — Regular session

  • XRP slipped to around $2.12 following a retreat from its recent peak.
  • A Senate committee delayed debate on a crypto market-structure bill following objections from Coinbase.
  • As Ripple expands further into Europe, it highlighted a preliminary licence from Luxembourg.

XRP dropped roughly 3% to near $2.12 on Thursday, retreating from a high of $2.17 recorded in the previous 24 hours.

The dip follows a setback in Washington’s push to regulate crypto. The Senate Banking Committee postponed a scheduled debate on draft legislation aimed at creating a regulatory framework for digital assets after Coinbase CEO Brian Armstrong voiced opposition to the bill as it stands. “We’d rather have no bill than a bad bill,” Armstrong said. Chairman Tim Scott indicated negotiations are ongoing. Reuters

Scott’s committee planned to hold an executive session Thursday to review H.R.3633, the Digital Asset Market Clarity Act of 2025. However, the committee’s hearing page now shows the session as postponed.

Ripple, known for its XRP token, pushed licensing news on Wednesday, revealing it had won preliminary approval for an Electronic Money Institution (EMI) licence from Luxembourg’s financial watchdog, the CSSF. This follows last week’s nod from U.K. regulators. “The EU was amongst the first major jurisdictions to introduce comprehensive digital assets regulation,” said Ripple President Monica Long. Cassie Craddock, Ripple’s managing director for UK & Europe, described Luxembourg as “a premier hub for financial innovation.” Ripple

An EMI licence acts as a regulatory green light, allowing payments companies to issue electronic money and operate payment services under supervision. Ripple is banking on this as it pushes its cross-border payments offering.

Bitcoin held steady near $95,500 as ether lingered close to $3,329. XRP slipped roughly 1.8%, with a number of other major tokens also drifting lower, according to data from Investing.com.

The risks, however, are clear. A drawn-out battle over the Senate bill—or tweaks that alter stablecoin rules, like capping “rewards”—could leave the sector in regulatory limbo. XRP often moves with overall market risk appetite, even when news hits specific to the company.

Traders are eyeing a fresh date for the Senate markup and whether Coinbase will rejoin talks. Crypto desks sensitive to macro moves are also focused on the Federal Reserve’s policy meeting set for Jan. 27-28, with the decision expected on Jan. 28.

Stock Market Today

  • Wall Street Faces Key Inflation Report as Federal Reserve Leadership Changes
    June 10, 2026, 5:11 AM EDT. The U.S. May inflation report, due at 8:30 a.m. ET, could disrupt record-high stock markets amid a leadership change at the Federal Reserve. Kevin Warsh recently succeeded Jerome Powell as Fed chair during a time of rising inflation pressures following geopolitical tensions that increased energy prices. The trailing 12-month inflation rate is expected to climb to 4.18%, up from 3.8% in April, fueled by higher energy costs after disruptions to global oil supply. Core Personal Consumption Expenditures (PCE), a critical inflation measure excluding energy and food, is also rising, signaling inflationary pressures extending beyond fuel. Investors will closely watch this data for clues on the Federal Open Market Committee's next move on interest rates, which have been cut six times since September 2024 to support the economy. The report holds significant influence over Wall Street's near-term direction.

Latest articles

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

10 June 2026
Roche’s participation certificates climbed 1.07% to CHF 322.20 after announcing a $2.3 billion deal with Nurix Therapeutics for late-stage blood-cancer drug bexobrutideg, planned to enter Phase 3 trials this summer in CLL, as investors weigh the asset’s potential to offset losses from expiring patents and drive mid-single-digit sales growth in 2026.
YY Group Shares Jump Premarket on Humanoid Robot Move

YY Group Shares Jump Premarket on Humanoid Robot Move

10 June 2026
YYGH jumped to $0.19 in early pre-market after announcing deployment of Unitree G1 humanoid robots for facility management, aiming to turn operational know-how into higher-margin data assets, but the stock remains volatile near record lows after a recent reverse split and has not confirmed robot-driven revenue or margin gains.
Tencent Shares Gain After $4.66B Bond Sale Seen Fueling AI Bets

Tencent Shares Gain After $4.66B Bond Sale Seen Fueling AI Bets

10 June 2026
Tencent shares jumped 3.22% to HK$467.80 after the company priced a larger-than-expected US$4.66 billion dual-currency bond deal, drawing over US$17 billion in orders and allowing tighter pricing, as investors weighed Tencent’s ability to fund rising AI investments while maintaining strong cash flow and ongoing share buybacks.
PAVS Stock Jumps Again, $195M Share Sale Filing in Focus

PAVS Stock Jumps Again, $195M Share Sale Filing in Focus

10 June 2026
Paranovus Entertainment Technology shares jumped 19.6% premarket after filing plans for an at-the-market share sale of up to $194.99 million—an unusually large amount compared to its $1.07 million market value—raising dilution risks as the company can sell shares at prevailing prices with no minimums, while recent trading has been highly volatile and underlying operations remain limited.
POET Technologies stock climbs before the bell as call-option volume spikes
Previous Story

POET Technologies stock climbs before the bell as call-option volume spikes

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop